Bridging Radiotherapy prior to Brexucabtagene Autoleucel CAR T-Cell Therapy in Mantle Cell Lymphoma

被引：0
|
作者：
Figura, N. [1 ]
Sim, A. [1 ]
Dahiya, S. [2 ,3 ]
Lutfi, F. [2 ,3 ]
Rapoport, A. [2 ,3 ]
Mohindra, P. [4 ]
Dohm, A. [1 ]
Chavez, J. [5 ]
Shah, B. [5 ]
Khimani, F. [6 ]
Lazaryan, A. [6 ]
Davila, M. [6 ]
Bachmeier, C. [6 ]
Nishihori, T. [6 ]
Liu, H. [6 ]
Kim, S. [1 ]
Locke, F. [6 ]
Jain, M. [6 ]
Robinson, T. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[2] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Greenebaum Comprehens Ctr, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Bone & Marrow Transplant & Cellular Immunoth, Tampa, FL USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 161卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1075
引用
收藏
页码：S894 / S895
页数：2
相关论文
共 50 条
  • [21] Multi -Institutional Update on Bridging Radiotherapy in Relapsed or Refractory Large B-Cell Lymphoma Patients Prior to CAR T-Cell Therapy
    Ababneh, H.
    Ng, A.
    Frigault, M. J.
    Jacobson, C.
    Patel, C. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E606 - E606
  • [22] Radiotherapy as bridging strategy in Large B-cell lymphoma patients selected for CAR T-cell therapy
    Niezink, A.
    Beijert, M.
    van Doesum, J.
    Muijs, C. T.
    Langendijk, J. A.
    Busz, D. M.
    Crijns, A. P.
    van Meerten, T.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S137 - S138
  • [23] Outcomes of Bridging and Salvage Radiotherapy in Relapsed or Refractory Mantle Cell Lymphoma Patients Undergoing CD19-Targeted CAR T-Cell Therapy
    Ababneh, H.
    Frigault, M.
    Patel, C. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E456 - E456
  • [24] Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis
    Khurana, Arushi
    Dalland, Joanna C.
    Young, Jason R.
    Inwards, David J.
    Paludo, Jonas
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (08) : E298 - E301
  • [25] Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma: Real-world experience from the United States lymphoma CAR T consortium.
    Jain, Preetesh
    Wang, Yucai
    Locke, Frederick L.
    Munoz, Javier
    Beitinjaneh, Amer
    Frank, Matthew Joshua
    Dahiya, Saurabh
    Jacobs, Miriam T.
    Hill, Brian T.
    Lekakis, Lazaros J.
    Miklos, David Bernard
    Ghobadi, Armin
    Neelapu, Sattva Swarup
    Lin, Yi
    Wang, Michael
    Jain, Michael D.
    Maurer, Matthew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse
    Vu, Khoan
    Frank, Matthew J.
    BLOOD ADVANCES, 2023, 7 (03) : 375 - 378
  • [27] Radiotherapy Is an Excellent Bridging Strategy in Large B-Cell Lymphoma Patients Selected for CAR T-Cell Therapy
    Niezink, Anne
    van Doesum, Jaap
    Beijert, Max
    Nijland, Marcel
    Langendijk, Hans
    Busz, Dianne
    Crijns, Anne P. G.
    Huls, Gerwin A.
    Van Meerten, Tom
    BLOOD, 2021, 138
  • [28] Cladribine and Cyclophosphamide Lymphodepletion Prior to Brexucabtagene Autoleucel in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma
    Ionescu, Filip
    Faramand, Rawan
    Bailey, Hanna
    Bachmeier, Christina A.
    DiMaggio, Elizabeth
    Mohammed, Turab
    Isenalumhe, Leidy Lismeris
    Locke, Frederick L.
    Jain, Michael D.
    Shah, Bijal D.
    BLOOD, 2023, 142
  • [29] Multi-omics profiling can predict for relapse and response to brexucabtagene autoleucel CAR-Tcell therapy in patients with mantle cell lymphoma
    Jiang, Vivian Changying
    Hao, Dapeng
    Jain, Preetesh
    Li, Yijing
    Cai, Qingsong
    Liu, Yang
    Che, Yuxuan
    Vargas, Jovanny
    Yao, Yixin
    Nie, Lei
    Dai, Enyu
    Han, Guangchun
    Wang, Ruiping
    Rai, Kunal
    Futreal, Andrew
    Flowers, Christopher
    Wang, Linghua
    Wang, Michael
    CANCER RESEARCH, 2022, 82 (12)
  • [30] COST-EFFECTIVENESS OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL, CAR-T) FOR THE TREATMENT OF RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN GREECE
    Loupas, M. A.
    Theodoratou, D.
    Kourlaba, G.
    VALUE IN HEALTH, 2022, 25 (12) : S112 - S112
12345